-+ 0.00%
-+ 0.00%
-+ 0.00%

Senti Biosciences Q1 EPS $(0.14) Beats $(0.36) Estimate, Sales $16.000K

Benzinga·05/14/2026 12:46:48
Listen to the news
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.36) by 61.11 percent. This is a 90.07 percent increase over losses of $(1.41) per share from the same period last year. The company reported $16.000 thousand in sales this quarter.